This clinical trial investigates the use of sodium fluorescein-guided resection in pediatric neurosurgical tumors. Sodium fluorescein is a dye which is bright under fluorescent light and may be used to help surgeons see where the tumor is. Using a special light filter and a microscope, surgeons may use the dye to see the area of the tumor and make it easier for them to remove brain and spinal tumors.
Additional locations may be listed on ClinicalTrials.gov for NCT03752203.
See trial information on ClinicalTrials.gov for a list of participating sites.
PRIMARY OBJECTIVE:
I. To study the utility of fluorescein sodium injection (sodium fluorescein) when used in conjunction with a surgical microscope equipped with fluorescent filters in the resection of pediatric central nervous system tumors (i.e. brain tumors and spinal tumors).
OUTLINE:
Patients receive sodium fluorescein intravenously (IV) over 10 seconds prior to surgery.
After completion of study treatment, patients are followed up to 2 months.
Trial PhaseNo phase specified
Trial Typebasic science
Lead OrganizationChildren's Hospital Colorado
Principal InvestigatorTodd Cameron Hankinson
